Diabetes Treatment Regimen as a Determinant of Lipid Goal Attainment in Patients with Type 2 Diabetes Mellitus Receiving Atorvastatin Therapy
Evaluating the association between antidiabetic treatment intensity and residual lipid risk among atorvastatin-treated patients with type 2 diabetes mellitus and dyslipidemia found no statistically significant association was observed.
S. Hasan, Bassim I. Mohammad
· 0 citations